title: Stent fracture: a new villain of the village.
abstract: Stent strut fracture (SSF) may be an important complication after drug-eluting stent (DES) implantation particularly in patients undergoing sirolimus-eluting stent (SES) implantation. The occurrence of SSF at 6 to 9 months after the SES implantation, which was relatively common, resulted in a higher rate of focal in-stent restenosis. Although this angiographic unfavorable outcome did not lead to an increased risk of adverse cardiac events in the current study, we believe that large-scale prospective studies are needed to elucidate the exact pathophysiology and clinical sequela of the stent strut fracture, including bare metal stents.
authors.forename: Turgay
authors.initials: T
authors.lastname: Celik
authors.forename: Atila
authors.initials: A
authors.lastname: Iyisoy
authors.forename: Bekim
authors.initials: B
authors.lastname: Jata
authors.forename: Cagdas U
authors.initials: CU
authors.lastname: Yuksel
authors.forename: Ersoy
authors.initials: E
authors.lastname: Isik
mesh_terms: D003327:Coronary Disease / Q000503:physiopathology / Q000628:therapy*; D023903:Coronary Restenosis / Q000209:etiology* / Q000503:physiopathology; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D006801:Humans